Scarica l'app Stockscreener
1.68
1.75%
-0.03
Precedente Chiudi:
$1.71
Aprire:
$1.72
Volume 24 ore:
170.24K
Relative Volume:
0.75
Capitalizzazione di mercato:
$27.00M
Reddito:
-
Utile/perdita netta:
$-8.29M
Rapporto P/E:
-2.40
EPS:
-0.7
Flusso di cassa netto:
$-6.47M
1 W Prestazione:
+0.00%
1M Prestazione:
+20.00%
6M Prestazione:
+51.35%
1 anno Prestazione:
-23.64%
Intervallo 1D:
$1.65
$1.75
Intervallo di 1 settimana:
$1.54
$1.78
Portata 52W:
$0.94
$2.3499
NanoViricides Inc Stock (NNVC) Company Profile
Nome
NanoViricides Inc
Settore
Industria
Telefono
203-937-6137
Indirizzo
1 Controls Drive, Shelton, CT
Confronta NNVC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NNVC
NanoViricides Inc
|
1.68 | 27.48M | 0 | -8.29M | -6.47M | -0.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
NanoViricides Inc Stock (NNVC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2015-02-11 | Iniziato | Midtown Partners | Strong Buy |
NanoViricides Inc Borsa (NNVC) Ultime notizie
Why NanoViricides Inc. stock attracts strong analyst attentionStrong Buy Recommendations - Metal.it
What drives NanoViricides Inc. stock priceConsistently outstanding ROI - Autocar Professional
What analysts say about NanoViricides Inc. stockExtraordinary earning power - Autocar Professional
Is NanoViricides Inc. a good long term investmentFree Trend-Following Techniques - Autocar Professional
Is NanoViricides Inc. stock a growth or value playFree Stock Chart Pattern Guide - jammulinksnews.com
NanoViricides Discusses the Multi-Billion-Dollar Potential of Its Broad-Spectrum Drug NV-387; Its Effectiveness Against Influenza, Coronaviruses, RSV, MPox and Now Measles Expected to Drive Value - Greenville Online
About Us - FinancialContent
NanoViricides eyes revenue opportunities with broad-spectrum antiviral NV-387 - Proactive financial news
NanoViricides (NNVC) Highlights Potential of Antiviral Drug NV-3 - GuruFocus
Multi-Billion Dollar Opportunity: NanoViricides' New Drug Fights COVID, Flu, RSV and Measles with Single Treatment - Stock Titan
NanoViricides Inc. Stock Analysis and ForecastHigh-octane gains - jammulinksnews.com
How NanoViricides Inc. stock performs during market volatilityFree Consultation - Newser
Measles Now Has a DrugNV-387 Broad-Spectrum Antiviral Successful in Animal Studies, says NanoViricides - Lohud
NanoViricides says lead antiviral boosted survival in measles-infected mice - Proactive financial news
Breakthrough: New Drug NV-387 Could Be First-Ever Treatment for Measles as Global Cases Surge - Stock Titan
Mpox Antiviral Clinical Trial Advances as WHO Extends Global Emergency - Global Biodefense
WHO Extended Global Emergency Status of MPox EpidemicDevelopment of Treatment for MPox with NV-387 is Timely, Says NanoViricides - Pocono Record
NanoViricides Advances MPox Treatment Development Amid WHO's Extended Health Emergency - citybuzz -
NanoViricides says MPox drug candidate NV-387 poised for Phase II trial as WHO extends global health emergency - Proactive financial news
D.C. United Roofing Inc. Wins 2025 Consumer Choice Award for Roofing in Barrie - The Palm Beach Post
NanoViricides Inc Azioni (NNVC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.97%
0.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):